 | • レポートコード：QYR2104Z2091 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、エレクトロコンピテントセルのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クローン化コンピテントセル、アグロバクテリウム・ツメファシエンスコンピテントセル、発現コンピテントセル）、用途別市場規模（サブクローニング・ルーチンクローニング、ファージディスプレイライブラリー構築、毒性/不安定DNAクローニング、ハイスループットクローニング、タンパク質発現、突然変異誘発、一本鎖DNA産生、バクミド生成、Cre-lox組換え（PIR1/PIR2））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・エレクトロコンピテントセルの市場動向 ・企業の競争状況、市場シェア ・エレクトロコンピテントセルの種類別市場規模（クローン化コンピテントセル、アグロバクテリウム・ツメファシエンスコンピテントセル、発現コンピテントセル） ・エレクトロコンピテントセルの用途別市場規模（サブクローニング・ルーチンクローニング、ファージディスプレイライブラリー構築、毒性/不安定DNAクローニング、ハイスループットクローニング、タンパク質発現、突然変異誘発、一本鎖DNA産生、バクミド生成、Cre-lox組換え（PIR1/PIR2）） ・エレクトロコンピテントセルの北米市場規模2016-2027（アメリカ、カナダ） ・エレクトロコンピテントセルのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・エレクトロコンピテントセルのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エレクトロコンピテントセルの中南米市場規模2016-2027（メキシコ、ブラジル） ・エレクトロコンピテントセルの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck KGaA、Thermo Fisher Scientific、Agilent Technologies、Takara Bio、Promega Corporation、Beijing TransGen Biotech、GeneScript Corporation、Yeastern Biotech、New England Biolabs、QIAGEN N.V.、OriGene Technologies、Lucigen、Zymo Research、Bio-Rad Laboratories、Bioline、Delphi Genetics、IBA GmBH、Cell Applications、BioDynamics Laboratory、Scarab Genomics） ・結論 |
Electrocompetent cells work using the electroporation process. Electrical pulses created pores that allows genetic material to permeate the bacterial membrane. Invitrogen offers a variety of electrocompetent E. coli cells to reliably clone your DNA with high efficiency.
Market Analysis and Insights: Global Electrocompetent Cells Market
The global Electrocompetent Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Electrocompetent Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Electrocompetent Cells market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Electrocompetent Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Electrocompetent Cells market.
Global Electrocompetent Cells Scope and Market Size
Electrocompetent Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Electrocompetent Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
Takara Bio
Promega Corporation
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Electrocompetent Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cloned Competent Cells
1.2.3 Agrobacterium tumefaciens Competent Cells
1.2.4 Expression Competent Cells
1.3 Market by Application
1.3.1 Global Electrocompetent Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable Dna Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded Dna Production
1.3.9 Bacmid creation
1.3.10 Cre-lox recombination (PIR1/PIR2)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Electrocompetent Cells Market Perspective (2016-2027)
2.2 Electrocompetent Cells Growth Trends by Regions
2.2.1 Electrocompetent Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Electrocompetent Cells Historic Market Share by Regions (2016-2021)
2.2.3 Electrocompetent Cells Forecasted Market Size by Regions (2022-2027)
2.3 Electrocompetent Cells Industry Dynamic
2.3.1 Electrocompetent Cells Market Trends
2.3.2 Electrocompetent Cells Market Drivers
2.3.3 Electrocompetent Cells Market Challenges
2.3.4 Electrocompetent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Electrocompetent Cells Players by Revenue
3.1.1 Global Top Electrocompetent Cells Players by Revenue (2016-2021)
3.1.2 Global Electrocompetent Cells Revenue Market Share by Players (2016-2021)
3.2 Global Electrocompetent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Electrocompetent Cells Revenue
3.4 Global Electrocompetent Cells Market Concentration Ratio
3.4.1 Global Electrocompetent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Electrocompetent Cells Revenue in 2020
3.5 Electrocompetent Cells Key Players Head office and Area Served
3.6 Key Players Electrocompetent Cells Product Solution and Service
3.7 Date of Enter into Electrocompetent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Electrocompetent Cells Breakdown Data by Type
4.1 Global Electrocompetent Cells Historic Market Size by Type (2016-2021)
4.2 Global Electrocompetent Cells Forecasted Market Size by Type (2022-2027)
5 Electrocompetent Cells Breakdown Data by Application
5.1 Global Electrocompetent Cells Historic Market Size by Application (2016-2021)
5.2 Global Electrocompetent Cells Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Electrocompetent Cells Market Size (2016-2027)
6.2 North America Electrocompetent Cells Market Size by Type
6.2.1 North America Electrocompetent Cells Market Size by Type (2016-2021)
6.2.2 North America Electrocompetent Cells Market Size by Type (2022-2027)
6.2.3 North America Electrocompetent Cells Market Size by Type (2016-2027)
6.3 North America Electrocompetent Cells Market Size by Application
6.3.1 North America Electrocompetent Cells Market Size by Application (2016-2021)
6.3.2 North America Electrocompetent Cells Market Size by Application (2022-2027)
6.3.3 North America Electrocompetent Cells Market Size by Application (2016-2027)
6.4 North America Electrocompetent Cells Market Size by Country
6.4.1 North America Electrocompetent Cells Market Size by Country (2016-2021)
6.4.2 North America Electrocompetent Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Electrocompetent Cells Market Size (2016-2027)
7.2 Europe Electrocompetent Cells Market Size by Type
7.2.1 Europe Electrocompetent Cells Market Size by Type (2016-2021)
7.2.2 Europe Electrocompetent Cells Market Size by Type (2022-2027)
7.2.3 Europe Electrocompetent Cells Market Size by Type (2016-2027)
7.3 Europe Electrocompetent Cells Market Size by Application
7.3.1 Europe Electrocompetent Cells Market Size by Application (2016-2021)
7.3.2 Europe Electrocompetent Cells Market Size by Application (2022-2027)
7.3.3 Europe Electrocompetent Cells Market Size by Application (2016-2027)
7.4 Europe Electrocompetent Cells Market Size by Country
7.4.1 Europe Electrocompetent Cells Market Size by Country (2016-2021)
7.4.2 Europe Electrocompetent Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Electrocompetent Cells Market Size (2016-2027)
8.2 Asia-Pacific Electrocompetent Cells Market Size by Type
8.2.1 Asia-Pacific Electrocompetent Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Electrocompetent Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Electrocompetent Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Electrocompetent Cells Market Size by Application
8.3.1 Asia-Pacific Electrocompetent Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Electrocompetent Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Electrocompetent Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Electrocompetent Cells Market Size by Region
8.4.1 Asia-Pacific Electrocompetent Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Electrocompetent Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Electrocompetent Cells Market Size (2016-2027)
9.2 Latin America Electrocompetent Cells Market Size by Type
9.2.1 Latin America Electrocompetent Cells Market Size by Type (2016-2021)
9.2.2 Latin America Electrocompetent Cells Market Size by Type (2022-2027)
9.2.3 Latin America Electrocompetent Cells Market Size by Type (2016-2027)
9.3 Latin America Electrocompetent Cells Market Size by Application
9.3.1 Latin America Electrocompetent Cells Market Size by Application (2016-2021)
9.3.2 Latin America Electrocompetent Cells Market Size by Application (2022-2027)
9.3.3 Latin America Electrocompetent Cells Market Size by Application (2016-2027)
9.4 Latin America Electrocompetent Cells Market Size by Country
9.4.1 Latin America Electrocompetent Cells Market Size by Country (2016-2021)
9.4.2 Latin America Electrocompetent Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Electrocompetent Cells Market Size (2016-2027)
10.2 Middle East & Africa Electrocompetent Cells Market Size by Type
10.2.1 Middle East & Africa Electrocompetent Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Electrocompetent Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Electrocompetent Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Electrocompetent Cells Market Size by Application
10.3.1 Middle East & Africa Electrocompetent Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Electrocompetent Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Electrocompetent Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Electrocompetent Cells Market Size by Country
10.4.1 Middle East & Africa Electrocompetent Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Electrocompetent Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Electrocompetent Cells Introduction
11.1.4 Merck KGaA Revenue in Electrocompetent Cells Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Electrocompetent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Electrocompetent Cells Introduction
11.3.4 Agilent Technologies Revenue in Electrocompetent Cells Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Electrocompetent Cells Introduction
11.4.4 Takara Bio Revenue in Electrocompetent Cells Business (2016-2021)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Electrocompetent Cells Introduction
11.5.4 Promega Corporation Revenue in Electrocompetent Cells Business (2016-2021)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Electrocompetent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2016-2021)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Electrocompetent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Electrocompetent Cells Business (2016-2021)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Electrocompetent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Electrocompetent Cells Business (2016-2021)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Electrocompetent Cells Introduction
11.9.4 New England Biolabs Revenue in Electrocompetent Cells Business (2016-2021)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Electrocompetent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Electrocompetent Cells Business (2016-2021)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Electrocompetent Cells Introduction
11.11.4 OriGene Technologies Revenue in Electrocompetent Cells Business (2016-2021)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Electrocompetent Cells Introduction
11.12.4 Lucigen Revenue in Electrocompetent Cells Business (2016-2021)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Electrocompetent Cells Introduction
11.13.4 Zymo Research Revenue in Electrocompetent Cells Business (2016-2021)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Electrocompetent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2016-2021)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Electrocompetent Cells Introduction
11.15.4 Bioline Revenue in Electrocompetent Cells Business (2016-2021)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Electrocompetent Cells Introduction
11.16.4 Delphi Genetics Revenue in Electrocompetent Cells Business (2016-2021)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Electrocompetent Cells Introduction
11.17.4 IBA GmBH Revenue in Electrocompetent Cells Business (2016-2021)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Electrocompetent Cells Introduction
11.18.4 Cell Applications Revenue in Electrocompetent Cells Business (2016-2021)
11.18.5 Cell Applications Recent Development
11.18 BioDynamics Laboratory
.1 BioDynamics Laboratory Company Details
.2 BioDynamics Laboratory Business Overview
.3 BioDynamics Laboratory Electrocompetent Cells Introduction
.4 BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2016-2021)
.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Electrocompetent Cells Introduction
11.20.4 Scarab Genomics Revenue in Electrocompetent Cells Business (2016-2021)
11.20.5 Scarab Genomics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Electrocompetent Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cloned Competent Cells
Table 3. Key Players of Agrobacterium tumefaciens Competent Cells
Table 4. Key Players of Expression Competent Cells
Table 5. Global Electrocompetent Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Electrocompetent Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Electrocompetent Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Electrocompetent Cells Market Share by Regions (2016-2021)
Table 9. Global Electrocompetent Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Electrocompetent Cells Market Share by Regions (2022-2027)
Table 11. Electrocompetent Cells Market Trends
Table 12. Electrocompetent Cells Market Drivers
Table 13. Electrocompetent Cells Market Challenges
Table 14. Electrocompetent Cells Market Restraints
Table 15. Global Electrocompetent Cells Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Electrocompetent Cells Market Share by Players (2016-2021)
Table 17. Global Top Electrocompetent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Electrocompetent Cells as of 2020)
Table 18. Ranking of Global Top Electrocompetent Cells Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Electrocompetent Cells Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Electrocompetent Cells Product Solution and Service
Table 22. Date of Enter into Electrocompetent Cells Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Electrocompetent Cells Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Electrocompetent Cells Revenue Market Share by Type (2016-2021)
Table 26. Global Electrocompetent Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Electrocompetent Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Electrocompetent Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Electrocompetent Cells Revenue Market Share by Application (2016-2021)
Table 30. Global Electrocompetent Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Electrocompetent Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Electrocompetent Cells Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Electrocompetent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Electrocompetent Cells Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Electrocompetent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Electrocompetent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Electrocompetent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Electrocompetent Cells Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Electrocompetent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Electrocompetent Cells Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Electrocompetent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Electrocompetent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Electrocompetent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Electrocompetent Cells Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Electrocompetent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Electrocompetent Cells Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Electrocompetent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Electrocompetent Cells Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Electrocompetent Cells Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Electrocompetent Cells Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Electrocompetent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Electrocompetent Cells Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Electrocompetent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Electrocompetent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Electrocompetent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Electrocompetent Cells Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Electrocompetent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Electrocompetent Cells Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Electrocompetent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Electrocompetent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Electrocompetent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck KGaA Company Details
Table 63. Merck KGaA Business Overview
Table 64. Merck KGaA Electrocompetent Cells Product
Table 65. Merck KGaA Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 66. Merck KGaA Recent Development
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Electrocompetent Cells Product
Table 70. Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. Agilent Technologies Company Details
Table 73. Agilent Technologies Business Overview
Table 74. Agilent Technologies Electrocompetent Cells Product
Table 75. Agilent Technologies Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 76. Agilent Technologies Recent Development
Table 77. Takara Bio Company Details
Table 78. Takara Bio Business Overview
Table 79. Takara Bio Electrocompetent Cells Product
Table 80. Takara Bio Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 81. Takara Bio Recent Development
Table 82. Promega Corporation Company Details
Table 83. Promega Corporation Business Overview
Table 84. Promega Corporation Electrocompetent Cells Product
Table 85. Promega Corporation Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 86. Promega Corporation Recent Development
Table 87. Beijing TransGen Biotech Company Details
Table 88. Beijing TransGen Biotech Business Overview
Table 89. Beijing TransGen Biotech Electrocompetent Cells Product
Table 90. Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 91. Beijing TransGen Biotech Recent Development
Table 92. GeneScript Corporation Company Details
Table 93. GeneScript Corporation Business Overview
Table 94. GeneScript Corporation Electrocompetent Cells Product
Table 95. GeneScript Corporation Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 96. GeneScript Corporation Recent Development
Table 97. Yeastern Biotech Company Details
Table 98. Yeastern Biotech Business Overview
Table 99. Yeastern Biotech Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 100. Yeastern Biotech Recent Development
Table 101. New England Biolabs Company Details
Table 102. New England Biolabs Business Overview
Table 103. New England Biolabs Electrocompetent Cells Product
Table 104. New England Biolabs Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 105. New England Biolabs Recent Development
Table 106. QIAGEN N.V. Company Details
Table 107. QIAGEN N.V. Business Overview
Table 108. QIAGEN N.V. Electrocompetent Cells Product
Table 109. QIAGEN N.V. Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 110. QIAGEN N.V. Recent Development
Table 111. OriGene Technologies Company Details
Table 112. OriGene Technologies Business Overview
Table 113. OriGene Technologies Electrocompetent Cells Product
Table 114. OriGene Technologies Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 115. OriGene Technologies Recent Development
Table 116. Lucigen Company Details
Table 117. Lucigen Business Overview
Table 118. Lucigen Electrocompetent Cells Product
Table 119. Lucigen Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 120. Lucigen Recent Development
Table 121. Zymo Research Company Details
Table 122. Zymo Research Business Overview
Table 123. Zymo Research Electrocompetent Cells Product
Table 124. Zymo Research Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 125. Zymo Research Recent Development
Table 126. Bio-Rad Laboratories Company Details
Table 127. Bio-Rad Laboratories Business Overview
Table 128. Bio-Rad Laboratories Electrocompetent Cells Product
Table 129. Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 130. Bio-Rad Laboratories Recent Development
Table 131. Bioline Company Details
Table 132. Bioline Business Overview
Table 133. Bioline Electrocompetent Cells Product
Table 134. Bioline Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 135. Bioline Recent Development
Table 136. Delphi Genetics Company Details
Table 137. Delphi Genetics Business Overview
Table 138. Delphi Genetics Electrocompetent Cells Product
Table 139. Delphi Genetics Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 140. Delphi Genetics Recent Development
Table 141. IBA GmBH Company Details
Table 142. IBA GmBH Business Overview
Table 143. IBA GmBH Electrocompetent Cells Product
Table 144. IBA GmBH Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 145. IBA GmBH Recent Development
Table 146. Cell Applications Company Details
Table 147. Cell Applications Business Overview
Table 148. Cell Applications Electrocompetent Cells Product
Table 149. Cell Applications Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 150. Cell Applications Recent Development
Table 151. BioDynamics Laboratory Company Details
Table 152. BioDynamics Laboratory Business Overview
Table 153. BioDynamics Laboratory Electrocompetent Cells Product
Table 154. BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 155. BioDynamics Laboratory Recent Development
Table 156. Scarab Genomics Company Details
Table 157. Scarab Genomics Business Overview
Table 158. Scarab Genomics Electrocompetent Cells Product
Table 159. Scarab Genomics Revenue in Electrocompetent Cells Business (2016-2021) & (US$ Million)
Table 160. Scarab Genomics Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Electrocompetent Cells Market Share by Type: 2020 VS 2027
Figure 2. Cloned Competent Cells Features
Figure 3. Agrobacterium tumefaciens Competent Cells Features
Figure 4. Expression Competent Cells Features
Figure 5. Global Electrocompetent Cells Market Share by Application: 2020 VS 2027
Figure 6. Subcloning & Routine Cloning Case Studies
Figure 7. Phage Display Library Construction Case Studies
Figure 8. Toxic/Unstable Dna Cloning Case Studies
Figure 9. High-Throughput Cloning Case Studies
Figure 10. Protein Expression Case Studies
Figure 11. Mutagenesis Case Studies
Figure 12. Single-Stranded Dna Production Case Studies
Figure 13. Bacmid creation Case Studies
Figure 14. Cre-lox recombination (PIR1/PIR2) Case Studies
Figure 15. Electrocompetent Cells Report Years Considered
Figure 16. Global Electrocompetent Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Electrocompetent Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Electrocompetent Cells Market Share by Regions: 2020 VS 2027
Figure 19. Global Electrocompetent Cells Market Share by Regions (2022-2027)
Figure 20. Global Electrocompetent Cells Market Share by Players in 2020
Figure 21. Global Top Electrocompetent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Electrocompetent Cells as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Electrocompetent Cells Revenue in 2020
Figure 23. Global Electrocompetent Cells Revenue Market Share by Type (2016-2021)
Figure 24. Global Electrocompetent Cells Revenue Market Share by Type (2022-2027)
Figure 25. North America Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Electrocompetent Cells Market Share by Type (2016-2027)
Figure 27. North America Electrocompetent Cells Market Share by Application (2016-2027)
Figure 28. North America Electrocompetent Cells Market Share by Country (2016-2027)
Figure 29. United States Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Electrocompetent Cells Market Share by Type (2016-2027)
Figure 33. Europe Electrocompetent Cells Market Share by Application (2016-2027)
Figure 34. Europe Electrocompetent Cells Market Share by Country (2016-2027)
Figure 35. Germany Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Electrocompetent Cells Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Electrocompetent Cells Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Electrocompetent Cells Market Share by Region (2016-2027)
Figure 45. China Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Electrocompetent Cells Market Share by Type (2016-2027)
Figure 53. Latin America Electrocompetent Cells Market Share by Application (2016-2027)
Figure 54. Latin America Electrocompetent Cells Market Share by Country (2016-2027)
Figure 55. Mexico Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Electrocompetent Cells Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Electrocompetent Cells Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Electrocompetent Cells Market Share by Country (2016-2027)
Figure 61. Turkey Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Electrocompetent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Merck KGaA Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 66. Agilent Technologies Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 67. Takara Bio Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 68. Promega Corporation Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 69. Beijing TransGen Biotech Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 70. GeneScript Corporation Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 71. Yeastern Biotech Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 72. New England Biolabs Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 73. QIAGEN N.V. Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 74. OriGene Technologies Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 75. Lucigen Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 76. Zymo Research Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 77. Bio-Rad Laboratories Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 78. Bioline Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 79. Delphi Genetics Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 80. IBA GmBH Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 81. Cell Applications Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 82. BioDynamics Laboratory Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 83. Scarab Genomics Revenue Growth Rate in Electrocompetent Cells Business (2016-2021)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
世界のクローン化コンピテントセル市場規模・現状・予測（2021年-2027年） Competent cells, designed to take up foreign DNA from the surrounding at a higher efficiency, are routinely used in molecular cloning to propagate and maintain cloned DNA in plasmids. Market Analysis and Insights: Global Cloned Competent Cells Market The global Cloned Competent Cells market size is …- 世界の化学的コンピテントセル市場規模・現状・予測（2021年-2027年） Chemically competent cells are calcium chloride treated to facilitate attachment of the plasmid DNA to the competent cell membrane. Chemically competent cells are the best solution for general cloning and subcloning application Market Analysis and Insights: Global Chemically Competent Cells Market T…
- 世界のコンピテントセル市場規模・現状・予測（2021年-2027年） Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for a…
- 世界の発現用コンピテントセル市場規模・現状・予測（2021年-2027年） The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic pr…
- 世界の発現用コンピテントセル市場規模・現状・予測（2021年-2027年） Expressed Competent cells are bacterial cells that can accept extra-chromosomal DNA or plasmids (naked DNA) from the environment. ... Bacteria can also be made competent artificially by chemical treatment and heat shock to make them transiently permeable to DNA. Market Analysis and Insights: Global …